Full Length Research Paper
References
Amayo A, Obara W (2004). Serum Prostate Specific Antigen Levels in Men with Benign Prostatic Hyperplasia and Cancer of Prostate. East Afr. Med. J. 81:1. Crossref |
||||
Lodding P, Aus G, Bergdah S, Frösing R, Lilja H, Pihl CG, Hugosson J (1998). Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen. J. Urol. 159(3):899-903. Crossref |
||||
Berman JJ, Moore GW, Alonsozana ELC, Mamo GF (1994). Elevated prostate specific antigen level and the negative prostate biopsy. South Med. J. 87(2):290-291. Crossref |
||||
Catalona WJ, Partin AW, Slawin KM, Brawer MK, Flanigan RC, Patel A (1998). Use of the percentage of free prostate-specific antigen to enhance differentiation of prostate cancer from benign prostatic disease: a prospective multicenter clinical trial. JAMA 279:1542–7. Crossref |
||||
Chawla R, Rebecca Abraham, U Arora, Kim Mammen (2003) Effect of Urinary retention on the levels of prostate specific antigen (PSA) and prostate acid phosphatase (PAP) in prostate disease. Indian J. Urol. 19:120-4 | ||||
Di Sant'Agnese PA (1992). Neuroendocrine differentiation in human prostatic carcinoma. Hum. Pathol. 23:287-296. Crossref |
||||
Bostwick DG, Qian J, Hossain D (2008). Non-neoplastic diseases of the prostate. In: Bostwick DG, Qian J, Hossain D (eds.), Urologic Surgical Pathology. 1st Edition, St Louis, USA. Crossref |
||||
Farnswork WE (1973). Human prostatic reverse transcriptase and RNA-virus. Urol. Res. 1:106. | ||||
Ferro MA, Barnes I, Roberts JB, Smith PJ (1987) Tumor markers in prostatic carcinoma: A comparison of prostate-specific antigen with acid phosphatase. Br. J. Urol. 60:69-73. Crossref |
||||
Foster CS, Deshmukh M (1992). Grading prostate cancer. In: Foster CS, Botwick DG (eds.), Pathology of Carcinoma of Prostate. Philadelphia: WB Saunders. 70(Suppl 0):233-234. | ||||
Gupta NP, Ansari MS, Dass SC (2005). Transrectal Ultrasound Guided Biopsy (TRUS) guided prostate biopsy. Indian J. Cancer 42(3):151-154. Crossref |
||||
Iczkowski KA, Basselor TJ, Schwob VS (1998). The diagnosis of "suspicious for malignancy" in prostate biopsies: predictive value for cancer. Urology 51:749-757. Crossref |
||||
McNeal JE (1978). Origin and evaluation of benign prostatic enlargement. Invest. Urol.15:340-345. Pubmed |
||||
Okada K, Kojima M, Naya Y, Kamoi K (2000). Correlation of histological inflammation in needle biopsy specimens with serum prostate specific antigen levels in men with negative biopsy for prostate cancer. Urology 55(6):892-898. Crossref |
||||
Warhol MJ, Longtine JA (1985). The ultrastructural localization of prostatic specific antigen and prostatic acid phosphatase in hyperplastic and neoplastic human prostates. J. Urol. 134:607-613. Pubmed |
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0